Results 31 to 40 of about 2,041 (194)

Juvenile Systemic Lupus Erythematosus Presenting with Esophagitis and Severe Oral Mucositis

Case Reports in Rheumatology, Volume 2021, Issue 1, 2021., 2021
We present a case of a previously healthy adolescent female who developed severe oral mucositis and acute esophagitis as her presenting symptoms of juvenile systemic lupus erythematosus. Mucositis involving the lips is infrequently reported in systemic lupus erythematosus, and to our knowledge, this is the first reported case of acute, non‐infectious ...
Emily Schildt, Kristen L Sessions, Deirdre De Ranieri, Ljudmila Stojanovich   +3 more
wiley   +1 more source

Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus

Frontiers in Pediatrics, 2019
Juvenile-onset systemic lupus erythematosus (JSLE) is a rare, heterogeneous multisystem autoimmune disease that can affect any organ, and present with diverse clinical and serological manifestations. Vasculitis can be a feature of JSLE.
Eve M. D. Smith, Eve M. D. Smith, Hanna Lythgoe, Christian M. Hedrich, Christian M. Hedrich   +4 more
doaj   +1 more source

Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus [PDF]

, 2009
OBJECTIVES: To evaluate the dietary intake of children and adolescents with juvenile idiopathic arthritis (JIA) and juvenile systemic lupus erythematosus (JSLE) using a 24-hour diet recall and relating it to the patients clinical and anthropometric ...
Caetano, Michelle Caetano, Hilário, Maria Odete Esteves, Ortiz, Thaís Tobaruela, Sarni, Roseli Oselka Saccardo, Silva, Simone Guerra Lopes, Souza, Fabíola Isabel Suano, Terreri, Maria Teresa Ramos Ascensão   +6 more
core   +3 more sources

Differences in disease phenotype and severity in SLE across age groups [PDF]

, 2016
OBJECTIVES: Significant differences have been reported in disease phenotype and severity of systemic lupus erythematosus (SLE) presenting in different age groups. Most indicate a more severe phenotype in juvenile-onset SLE (JSLE). There have been limited
Ambrose, N, Beresford, MW, Galloway, J, Grp, UKJSLE Study, Ionnoau, Y, Isenberg, DA, Morgan, TA   +6 more
core   +1 more source

Ocular changes due to the treatment of juvenile systemic lupus erythematosus [PDF]

, 2011
OBJECTIVE: To assess retrospectively the ocular changes in children and adolescents with juvenile systemic lupus erythematosus (JSLE) in a tertiary pediatric rheumatology service.
Finamor, Luciana Peixoto dos Santos, Fraga, Melissa Mariti, Hilário, Maria Odete Esteves, Len, Claudio Arnaldo, Matos, Kimble Teixeira Fonseca, Muccioli, Cristina, Terreri, Maria Teresa Ramos Ascensão   +6 more
core   +3 more sources

P24 Correlation between serum autoantibodies and clinical manifestations in jSLE [PDF]

Poster presentations, 2020
Background Systemic Lupus Erythematosus (SLE) has a large clinical spectrum, ranging from mild to severe disease. Some studies have proven correlations between specific autoantibodies and particular clinical manifestations. The aim is to assess if there is any correlation between autoantibodies and clinical manifestations in our sample.
Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito   +3 more
openaire   +1 more source

IgA vasculitis (Henoch – Schönlein Purpura) as the first manifestation of juvenile Systemic Lupus Erythematosus: Case-control study and systematic review

BMC Pediatrics, 2019
Background We have recognized 15 children with jSLE and the antecedent of IgA vasculitis (HSP). This association is not broadly present in the literature.
Chiharu Murata, Ana Luisa Rodríguez-Lozano, Hayde Guadalupe Hernández-Huirache, Miriam Martínez-Pérez, Laura Andrea Rincón-Arenas, Esmeralda Nancy Jiménez-Polvo, Francisco Eduardo Rivas-Larrauri, Cecilia Solís-Galicia   +7 more
doaj   +1 more source

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature. [PDF]

Arthritis Rheumatol
Objective Patients with juvenile‐onset systemic lupus erythematosus (JSLE) have increased atherosclerosis risk. This study investigated novel atherosclerosis progression biomarkers in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) trial, the largest investigator‐led randomized control trial of atorvastatin versus placebo for ...
Peng J, Dönnes P, Ardoin SP, Schanberg LE, Lewandowski L, APPLE trial investigators and Childhood Rheumatology Research Alliance (CARRA), Robinson G, Jury EC, Ciurtin C.   +8 more
europepmc   +2 more sources

International validation of a urinary biomarker panel for identification of active lupus nephritis in children. [PDF]

, 2016
Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic
Beresford, MW, Corkhill, R, Ekdawy, D, Goilav, B, Jones, CA, Jorgensen, AL, Marks, SD, Midgley, A, Newland, P, Oni, L, Pilkington, C, Putterman, C, Rubinstein, T, Smith, EMD, Tullus, K, Wahezi, D   +15 more
core   +2 more sources

Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus

Pediatric Rheumatology Online Journal, 2023
Background This study aimed to describe the prevalence of the various clinical features and severity of juvenile systemic lupus erythematosus (jSLE) and to assess predictors of AQP4-Ab positivity in jSLE. In addition, we assessed the relationship of AQP4-
Yasmeen Shaaban, Hala EL-Marsafawy, Reham M El-Farahaty, Sherine El-Ziny, Ahmed M EL-Refaey   +4 more
doaj   +1 more source